A research-based.

Boehringer signs contract with Brigham to carry out long-term study system on oral anticoagulants Boehringer Ingelheim, a research-based, global pharmaceutical firm, today announced a multi-year contract with Brigham and Ladies's Medical center, an internationally recognized teaching affiliate marketer of Harvard Medical College known because of its excellence in individual care, medical training and research of outstanding youthful health professionals propranolol medicine http://propranolol-hcl.net . Under this contract, Brigham and Women's Hospital will carry out a long-term study plan to assess comparative security and effectiveness, and also prescribing patterns, of oral anticoagulants, including PRADAXA, for the reduced amount of stroke risk in U.S.